Analysis of risk factors for the efficacy of tirofiban in the treatment of acute ischemic stroke-Reference-Cited by-同舟云学术

Analysis of risk factors for the efficacy of tirofiban in the treatment of acute ischemic stroke

Published:2023-01-04 Issue:6 Volume:45 Page:538-543
ISSN:0161-6412
Container-title:Neurological Research
language:en
Short-container-title:Neurological Research

Author:

Liu Chong¹,Yin Lu²,Hu Yinqin¹,Shi Zhizhen¹,Zhu Qiaoyan¹,Xiao Qian¹,Li Guoyi¹,Cheng Jiwei¹,Hou Yangbo¹

Affiliation:

1. Department of Neurology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

2. Department of Rehabilitation, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Funder

Putuo District Health System Science and Technology Innovation Project

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/01616412.2022.2164447

Reference25 articles.

1. Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults

2. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

3. Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke

4. Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction

5. Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis